Verastem, INC Form 4 insider transactions

Daniel Calkins, CFO of Verastem, Inc., sold shares of common stock to cover statutory withholding requirements related to the vesting of restricted stock units.

Daniel Calkins, CFO of Verastem, Inc., sold shares of common stock to satisfy statutory withholding requirements related to the vesting of restricted stock units.

Daniel Calkins, CFO of Verastem, Inc., sold 55 shares of common stock on March 20, 2024, to satisfy statutory withholding requirements related to vesting restricted stock units.

Director Robert E. Gagnon sold Verastem (VSTM) shares on March 18th and 19th to cover statutory withholding requirements related to vesting restricted stock units.

Verastem's CEO, Dan Paterson, sold shares of common stock on March 18 and 19, 2024, to satisfy statutory withholding requirements related to the vesting of restricted stock units.

Director Brian M. Stuglik sold Verastem (VSTM) shares on March 18 and 19, 2024, to cover statutory withholding requirements related to vesting restricted stock units.

Director Paul A. Bunn participated in Verastem's option exchange program, cancelling high-priced options and receiving new options with a lower exercise price.

Director Brian M. Stuglik participated in Verastem's option exchange program, resulting in the cancellation of existing stock options and the grant of new options.

Director Eric K. Rowinsky participated in Verastem's option exchange program, canceling existing stock options with higher exercise prices in exchange for new options.

Director John Johnson participated in Verastem's option exchange program, cancelling higher-priced options and receiving new options with a lower exercise price.

Verastem's CEO, Dan Paterson, participated in the company's option exchange program, resulting in the cancellation of certain unexercised options and the grant of new stock options.

Verastem's Chief Financial Officer, Daniel Calkins, participated in an option exchange program, canceling existing options and receiving new grants with adjusted vesting schedules.

Michelle Robertson, a director at Verastem, Inc., participated in the company's option exchange program, resulting in the cancellation of existing stock options and the grant of new ones.

Michael Kauffman, a director at Verastem, Inc., participated in an option exchange program, cancelling existing stock options with exercise prices above $15.00 and receiving a new grant of options.